Levetiracetam Crescent

Levetiracetam, the active ingredient in Levetiracetam Crescent, is an anticonvulsant presented as a tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Crescent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizure activity across several seizure types.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: decreases the occurrence of rapid muscle jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias (e.g., neutropenia, thrombocytopenia) - Suicidal thoughts or behaviour - Severe skin rash - Multi‑organ hypersensitivity reactions

When prescribing or dispensing levetiracetam, several safety considerations should be observed. - Renal impairment: dose adjustment may be required based on renal function. - Hepatic dysfunction: monitor liver enzymes and clinical status. - Pregnancy: safety category unknown; weigh potential benefits against risks. - Concomitant CNS depressants: may increase sedation or respiratory depression. - Behavioral changes: monitor for mood swings, aggression, or depression. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: may reduce levetiracetam levels. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Other CNS depressants (e.g., benzodiazepines, opioids): increased sedation risk. - Fluconazole: may raise levetiracetam concentrations.